Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
If history is any guide, there may be trouble ahead for shares of CBRE Group (NYSE:CBRE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Within the commercial real estate industry, the lodging sector was among the most seriously impacted during the first year of the COVID-19 pandemic. But during the course of 2021, the sector began to regain some of its vitality, and many industry leaders believe this positive trend could continue into 2022.
CBRE Acquisition Holdings, Inc. (NYSE:CBAH) ("CBAH"), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination
The month of December shows an increasing number of SPAC deal votes.
SPAC merger votes can act as a catalyst, as the votes complete the last step in the merger process and change the company over to a new name and ticker that can help build recognition.
CBRE Group (NYSE:CBRE) reported quarterly earnings of $1.39 per share which beat the analyst consensus estimate of $1.16 by 19.83 percent. This is a 90.41 percent increase over earnings of $0.73 per share from the same